David P Southwell - Net Worth and Insider Trading
David P Southwell Net Worth
The estimated net worth of David P Southwell is at least $5 Million dollars as of 2024-06-05. David P Southwell is the Director of Rocket Pharmaceuticals Inc and owns about 114,784 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $3 Million. David P Southwell is the CEO of TScan Therapeutics Inc and owns about 171,569 shares of TScan Therapeutics Inc (TCRX) stock worth over $1 Million. David P Southwell is also the Director of PTC Therapeutics Inc and owns about 10,500 shares of PTC Therapeutics Inc (PTCT) stock worth over $398,055. Besides these, David P Southwell also holds First Eagle Alternative Capital BDC Inc (FCRD) . Details can be seen in David P Southwell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David P Southwell has not made any transactions after 2024-04-15 and currently still holds the listed stock(s).
Transaction Summary of David P Southwell
David P Southwell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David P Southwell owns 5 companies in total, including PTC Therapeutics Inc (PTCT) , Rocket Pharmaceuticals Inc (RCKT) , and Spero Therapeutics Inc (SPRO) among others .
Click here to see the complete history of David P Southwell’s form 4 insider trades.
Insider Ownership Summary of David P Southwell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PTCT | PTC Therapeutics Inc | 2023-04-17 | director |
RCKT | Rocket Pharmaceuticals Inc | 2024-04-15 | director & See Remarks |
SPRO | Spero Therapeutics Inc | 2018-02-01 | director |
2010-12-06 | director | ||
2022-05-18 | director & Chief Executive Officer |
David P Southwell Latest Holdings Summary
David P Southwell currently owns a total of 4 stocks. Among these stocks, David P Southwell owns 114,784 shares of Rocket Pharmaceuticals Inc (RCKT) as of April 15, 2024, with a value of $3 Million and a weighting of 55.85%. David P Southwell owns 171,569 shares of TScan Therapeutics Inc (TCRX) as of May 18, 2022, with a value of $1 Million and a weighting of 31.62%. David P Southwell also owns 10,500 shares of PTC Therapeutics Inc (PTCT) as of April 17, 2023, with a value of $398,055 and a weighting of 8.71%. The other 1 stocks First Eagle Alternative Capital BDC Inc (FCRD) have a combined weighting of 3.83% among all his current holdings.
Latest Holdings of David P Southwell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RCKT | Rocket Pharmaceuticals Inc | 2024-04-15 | 114,784 | 22.23 | 2,551,648 |
TCRX | TScan Therapeutics Inc | 2022-05-18 | 171,569 | 8.42 | 1,444,611 |
PTCT | PTC Therapeutics Inc | 2023-04-17 | 10,500 | 37.91 | 398,055 |
FCRD | First Eagle Alternative Capital BDC Inc | 2010-12-06 | 38,500 | 4.54 | 174,790 |
Holding Weightings of David P Southwell
David P Southwell Form 4 Trading Tracker
According to the SEC Form 4 filings, David P Southwell has made a total of 1 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the sale of 80,000 shares on April 15, 2024, which brought David P Southwell around $2 Million.
According to the SEC Form 4 filings, David P Southwell has made a total of 2 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 25,000 shares on May 18, 2022, which cost David P Southwell around $89,750.
According to the SEC Form 4 filings, David P Southwell has made a total of 3 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 11,429 shares on April 17, 2023, which brought David P Southwell around $583,222.
More details on David P Southwell's insider transactions can be found in the Insider Trading History of David P Southwell table.Insider Trading History of David P Southwell
- 1
David P Southwell Trading Performance
GuruFocus tracks the stock performance after each of David P Southwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Southwell is -2.03%. GuruFocus also compares David P Southwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Southwell within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David P Southwell's insider trading performs compared to the benchmark.
Performance of David P Southwell
David P Southwell Ownership Network
Ownership Network List of David P Southwell
Ownership Network Relation of David P Southwell
David P Southwell Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
David P Southwell is the director of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include Chief Medical Officer Lee Scott Golden , Chief Development Officer Matthew B. Klein , and Chief Business Officer Eric Pauwels .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, David P Southwell made 2 insider transaction in PTC Therapeutics Inc (PTCT) with a net sale of 21,429. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 25,597 shares made by Eric Pauwels , a net sale of 41,134 shares made by Christine Marie Utter , and a net sale of 28,914 shares made by Matthew B. Klein .
In summary, during the past 3 months, insiders sold 26,156 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 26,156 shares. During the past 18 months, 294,092 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 286,392 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
David P Southwell Mailing Address
Above is the net worth, insider trading, and ownership report for David P Southwell. You might contact David P Southwell via mailing address: C/o Inotek Pharmaceuticals Corporation, 91 Hartwell Avenue, Lexington Ma 02421.